Journal of Palliative Care · 2020 · 10 citations · 9 references
MedicineHealth Care ManagementOncologyEnd-of-life CareHealth Services ResearchPalliative CareCancer MortalityEnd-of-life Care PlanningEnd-of-life Decision MakingPalliative Care For CancerProstate CancerSupportive Care In CancerCare Quality MonitoringEnd-of-life Cancer MortalityHealthcare Data ModelingHealthcare ResourcesOutpatient Palliative CarePalliative Care ManagementProstate Cancer EpidemiologyProstate Cancer Mortality
INTRODUCTION: Current research on prostate cancer is heavily focused on early detection and new treatments. There is a lack of research on the overall morbidity prostate cancer survivors face and the amount of healthcare treatment they receive toward the end of their lives. Identifying these care needs will allow appropriate healthcare modeling, resource allocation and service re-design to ensure higher quality care toward the end of life. The aim of this study is to quantify and analyze the use of healthcare services by patients dying with but not necessarily of prostate cancer. METHODS: All patients who died with a diagnosis of prostate cancer during a 2-year period at a single hospital were included. Data on outpatient attendances, elective and emergency admissions and palliative care involvement in the 12 months prior to death were collected. RESULTS: A total of 77 patients were included and of these, 60 (78.0%) had 545 scheduled appointments with 473 (86.8%) attendances. More non-attendances occurred in the last 6 months of life; 56 vs 16, p < 0.001. Nurse led clinics doubled in the last 6 months of life, 117 vs 66. There were 173 admissions from 63 (81.8%) patients resulting in 1816 days inpatient stay. This averaged to 2.7 admissions per patient for 10.5 days per episode. 32 (41.6%) patients were seen by palliative care resulting in 192 visits in total. 78 (40.6%) were inpatient and 114 (59.4%) were community reviews. CONCLUSIONS: In the last year of life, prostate cancer patients use a considerable amount of healthcare resources. Understanding this clinical and economical burden is important for healthcare remodeling to provide better quality care that is cost effective.
9
Cancer incidence and mortality projections in the UK until 2035
C R Smittenaar, Kenneth Petersen, Kelley M. Stewart et al. · British Journal of Cancer · 2016 · 511 citations · Full text
Medicine, Biostatistics, Oncology +17